Cargando…

Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention

BACKGROUND: Individualised behaviour change interventions can result in greater effects than one-size-fits-all approaches. Factors linked to success include dynamic (vs. static) tailoring, and tailoring on behaviour, multiple theoretical variables, and participant characteristics. XP is a very rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainsbury, Kirby, Walburn, Jessica, Foster, Lesley, Morgan, Myfanwy, Sarkany, Robert, Weinman, John, Araujo-Soares, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114353/
https://www.ncbi.nlm.nih.gov/pubmed/34040885
http://dx.doi.org/10.1080/21642850.2020.1840379
_version_ 1783691043662725120
author Sainsbury, Kirby
Walburn, Jessica
Foster, Lesley
Morgan, Myfanwy
Sarkany, Robert
Weinman, John
Araujo-Soares, Vera
author_facet Sainsbury, Kirby
Walburn, Jessica
Foster, Lesley
Morgan, Myfanwy
Sarkany, Robert
Weinman, John
Araujo-Soares, Vera
author_sort Sainsbury, Kirby
collection PubMed
description BACKGROUND: Individualised behaviour change interventions can result in greater effects than one-size-fits-all approaches. Factors linked to success include dynamic (vs. static) tailoring, and tailoring on behaviour, multiple theoretical variables, and participant characteristics. XP is a very rare (∼100 UK patients) genetic disease, involving an inability to repair ultraviolet radiation (UVR)-induced damage, resulting in skin cancers and eye damage from an early age, and mean life expectancy of 32-years. Management involves rigorous UVR photoprotection, which is often inadequate, and no interventions have been published. UK-based care is personalised and delivered by a multidisciplinary team at the National XP Service in London. Following an intensive, mixed-methods formative phase with patients diagnosed with XP (n-of-1, qualitative interviews, objective UVR measurement, cross-sectional survey) and relevant stakeholder consultation (clinical and patient/public teams), the ‘XPAND’ intervention was developed. This paper describes the comprehensive and novel tailoring and personalisation processes used to deliver the intervention. METHODS: XPAND consists of core and personalised modules targeting cue-based (time of day, weather, symptoms), belief-based (motivation, priority), self-regulatory (effort, barriers, planning), and emotional (stress, self-consciousness, mental exhaustion) factors, social support, disclosure, habit, and willingness, using appropriately-matched BCTs. A-priori, phase I data and a baseline profiling questionnaire (data sources) were used to allocate modules to participants (‘personalisation’) and to adapt module content (‘tailoring’). Iterative decisions about delivery were based on patient response to feedback, identification of additional barriers (e.g. reasons for varying protection across contexts), and emergence of new barriers as improvements in protection were attempted or achieved (e.g. appearance concerns). CONCLUSIONS: Dynamic multi-level personalisation and tailoring based on mixed-methods in XPAND allowed for insights and decision-making not possible with cross-sectional quantitative or qualitative methods alone. Data collection and allocation/adaptation methods may be of use in other rare conditions where small patient numbers mean that within-participant, individual-level delivery is well-suited and feasible.
format Online
Article
Text
id pubmed-8114353
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Routledge
record_format MEDLINE/PubMed
spelling pubmed-81143532021-05-25 Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention Sainsbury, Kirby Walburn, Jessica Foster, Lesley Morgan, Myfanwy Sarkany, Robert Weinman, John Araujo-Soares, Vera Health Psychol Behav Med Research Article BACKGROUND: Individualised behaviour change interventions can result in greater effects than one-size-fits-all approaches. Factors linked to success include dynamic (vs. static) tailoring, and tailoring on behaviour, multiple theoretical variables, and participant characteristics. XP is a very rare (∼100 UK patients) genetic disease, involving an inability to repair ultraviolet radiation (UVR)-induced damage, resulting in skin cancers and eye damage from an early age, and mean life expectancy of 32-years. Management involves rigorous UVR photoprotection, which is often inadequate, and no interventions have been published. UK-based care is personalised and delivered by a multidisciplinary team at the National XP Service in London. Following an intensive, mixed-methods formative phase with patients diagnosed with XP (n-of-1, qualitative interviews, objective UVR measurement, cross-sectional survey) and relevant stakeholder consultation (clinical and patient/public teams), the ‘XPAND’ intervention was developed. This paper describes the comprehensive and novel tailoring and personalisation processes used to deliver the intervention. METHODS: XPAND consists of core and personalised modules targeting cue-based (time of day, weather, symptoms), belief-based (motivation, priority), self-regulatory (effort, barriers, planning), and emotional (stress, self-consciousness, mental exhaustion) factors, social support, disclosure, habit, and willingness, using appropriately-matched BCTs. A-priori, phase I data and a baseline profiling questionnaire (data sources) were used to allocate modules to participants (‘personalisation’) and to adapt module content (‘tailoring’). Iterative decisions about delivery were based on patient response to feedback, identification of additional barriers (e.g. reasons for varying protection across contexts), and emergence of new barriers as improvements in protection were attempted or achieved (e.g. appearance concerns). CONCLUSIONS: Dynamic multi-level personalisation and tailoring based on mixed-methods in XPAND allowed for insights and decision-making not possible with cross-sectional quantitative or qualitative methods alone. Data collection and allocation/adaptation methods may be of use in other rare conditions where small patient numbers mean that within-participant, individual-level delivery is well-suited and feasible. Routledge 2020-11-07 /pmc/articles/PMC8114353/ /pubmed/34040885 http://dx.doi.org/10.1080/21642850.2020.1840379 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sainsbury, Kirby
Walburn, Jessica
Foster, Lesley
Morgan, Myfanwy
Sarkany, Robert
Weinman, John
Araujo-Soares, Vera
Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title_full Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title_fullStr Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title_full_unstemmed Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title_short Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘XPAND’ intervention
title_sort improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the ‘xpand’ intervention
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114353/
https://www.ncbi.nlm.nih.gov/pubmed/34040885
http://dx.doi.org/10.1080/21642850.2020.1840379
work_keys_str_mv AT sainsburykirby improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT walburnjessica improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT fosterlesley improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT morganmyfanwy improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT sarkanyrobert improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT weinmanjohn improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention
AT araujosoaresvera improvingphotoprotectioninadultswithxerodermapigmentosumpersonalisationandtailoringinthexpandintervention